SSY Group Ltd
HKEX:2005
SSY Group Ltd
Revenue
SSY Group Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SSY Group Ltd
HKEX:2005
|
Revenue
HK$5.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Revenue
HK$11.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Revenue
¥13.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Revenue
¥28.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Revenue
HK$257.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Revenue
$630.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
25%
|
CAGR 10-Years
22%
|
|
SSY Group Ltd
Glance View
SSY Group Ltd. stands out as a significant player in the Chinese pharmaceutical industry, seamlessly interweaving its intricate supply chain operations with its robust manufacturing capabilities. Founded in 1994, the company has its roots in the scenic Hebei Province and has evolved into a powerful force in the realm of injectable pharmaceuticals and oral solutions. The organization primarily operates through its core segment—manufacturing and distributing intravenous infusion solutions. By leveraging cutting-edge technology and adhering to stringent quality standards, SSY Group has managed to capture a sizable share of the domestic market, ensuring a steady stream of revenue. The firm's prowess isn't limited to its pharmaceutical expertise. SSY Group's growth strategy involves a careful blend of organic expansion and strategic acquisitions, which enables it to broaden its product categories and penetrate new regional markets. By offering a wide variety of products ranging from antibiotics to anti-infection drugs, the company adeptly meets diverse healthcare needs while simultaneously driving profitability. Additionally, SSY Group bolsters its financial performance through its involvement in both research and development. By dedicating resources toward innovation, it aspires to maintain its competitive edge, producing high-value products that facilitate sustainable long-term growth. Thus, SSY Group's tightly-knit approach to blending manufacturing excellence with strategic growth initiatives paints a picture of a company adeptly navigating the challenges and opportunities of the healthcare sector.
See Also
What is SSY Group Ltd's Revenue?
Revenue
5.8B
HKD
Based on the financial report for Dec 31, 2024, SSY Group Ltd's Revenue amounts to 5.8B HKD.
What is SSY Group Ltd's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for SSY Group Ltd have been 3% over the past three years , 4% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet